. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 2-Aminopurine/adverse effects2-Aminopurine/analogs & derivatives2-Aminopurine/therapeutic useAbnormalities, Drug-Induced/etiologyAcyclovir/adverse effectsAcyclovir/analogs & derivativesAcyclovir/pharmacologyAcyclovir/therapeutic useAmantadine/adverse effectsAmantadine/therapeutic useAntiviral Agents/therapeutic useCidofovirContraindicationsCytosine/adverse effectsCytosine/analogs & derivativesCytosine/pharmacologyCytosine/therapeutic useDrug Resistance, MicrobialEye Infections, Viral/drug therapyFamciclovirFoscarnet/adverse effectsFoscarnet/therapeutic useGanciclovir/adverse effectsGanciclovir/therapeutic useHumansInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useKidney Diseases/chemically inducedLamivudine/adverse effectsLamivudine/therapeutic useOrganophosphonatesOrganophosphorus Compounds/adverse effectsOrganophosphorus Compounds/pharmacologyOrganophosphorus Compounds/therapeutic useProdrugs/therapeutic useRibavirin/adverse effectsRibavirin/therapeutic useRimantadine/therapeutic useTrifluridine/therapeutic useValacyclovirValine/adverse effectsValine/analogs & derivativesValine/therapeutic useVirus Diseases/drug therapy
Substances: See more » Antiviral AgentsInterferon-alphaOrganophosphonatesOrganophosphorus CompoundsProdrugsRimantadineLamivudinepenciclovirFoscarnet2-AminopurineRibavirinCytosineAmantadineValineCidofovirValacyclovirGanciclovirFamciclovirTrifluridineAcyclovir
Year: 1997 PMID: 9255238
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909